Global healthcare provider Zydus Cadila on Saturday said it received approval from the US Federal Drug Authority (USFDA) to market Amlodipine and Olmesartan Medoxomil tablets for the treatment of hypertension.
"The drug, meant for treating hypertension or to lower blood pressure with other anti-hypertensive agents, will be manufactured at our group's formulations manufacturing facility at the Pharma SEZ in Ahmedabad," said the company in a regulatory filing to the BSE.
The company also received the federal regulatory approval on September 21 to market its Itraconazole capsules to treat fungal infections.
--IANS
fb/vd
Disclaimer: No Business Standard Journalist was involved in creation of this content